| Literature DB >> 32116844 |
Abstract
BACKGROUND: Recently, magnetic resonance imaging (MRI) technology has been widely used to quantitatively analyze brain structure, morphology, and functional activities, as well as to clarify the neuropathological and neurobiological mechanisms of schizophrenia. However, although there have been many relevant results and conclusions, there has been no systematic assessment of this field. AIM: To analyze important areas of research utilizing MRI in studies of schizophrenia and explore major trends and the knowledge structure using bibliometric analysis.Entities:
Keywords: bibliometric analysis; co-occurrence analysis; magnetic resonance imaging; schizophrenia; social network analysis; strategic diagram
Year: 2020 PMID: 32116844 PMCID: PMC7019376 DOI: 10.3389/fpsyt.2020.00027
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 5Strategic diagrams for MRI studies on schizophrenia in three different periods. (A) Explanation of the strategic diagram. (B) Strategic diagram for MRI studies on schizophrenia in 2004–2008. The coordinate values of Cluster 1 are (0.40787, 0.07288), which locates it in Quadrant I. (C) Strategic diagram for MRI studies on schizophrenia in 2009–2013. (D) Strategic diagram for MRI studies on schizophrenia in 2014–2018. The coordinate values of Cluster 2 are (-0.39885, -0.37111), which locates it in Quadrant I. Clusters in each strategic diagram refer to the bi-clustering results presented in . The size of each single node is proportional to the number of high-frequency major MeSH terms/MeSH subheadings involved in each cluster ().
Figure 1The number of publications of MRI studies on schizophrenia in PubMed from 2004 to 2018.
Temporal distribution of publications of MRI studies on schizophrenia in PubMed from 2004 to 2018.
| Period | Rank | Country | Top journal | Author | |||
|---|---|---|---|---|---|---|---|
| Name | Publications, n (%) | Title | Publication, n (%) | Name | Number of papers | ||
| 2004- 2008 | 1 | United States | 427(44.11%) | 162(16.71%) | Shenton ME | 35 | |
| 2 | England | 178(18.39%) | 86(8.88%) | McCarley RW | 34 | ||
| 3 | Netherlands | 178(18.39%) | 77(7.95%) | Lawrie SM | 30 | ||
| 4 | Ireland | 96(9.92%) | 73(7.53%) | Johnstone EC | 29 | ||
| 5 | Germany | 42(4.34%) | 67(6.91%) | Keshavan MS | 26 | ||
| Total | 921(95.15%) | 465(47.98%) | |||||
| 2009- 2013 | 1 | United States | 574(39.70%) | 242(16.69%) | Calhoun VD | 58 | |
| 2 | Netherlands | 285(19.71%) | 132(9.10%) | Shenton ME | 41 | ||
| 3 | England | 273(18.88%) | 114(7.86%) | Keshavan MS | 40 | ||
| 4 | Ireland | 144(9.96%) | 96(6.62%) | Kubicki M | 37 | ||
| 5 | Germany | 70(4.84%) | 61(4.20%) | Kahn RS | 35 | ||
| Total | 1346(93.09%) | 645(44.47%) | |||||
| 2014- 2018 | 1 | United States | 573(37.26%) | 222(14.37%) | Calhoun VD | 77 | |
| 2 | Netherlands | 425(27.63%) | 125(8.09%) | Pearlson GD | 36 | ||
| 3 | England | 311(20.22%) | 81(5.24%) | Andreassen OA | 36 | ||
| 4 | Ireland | 74(4.81%) | 63(4.08%) | Agartz I | 35 | ||
| 5 | Germany | 45(2.93%) | 62(4.01%) | Guo W | 34 | ||
| Total | 1428(92.85%) | 553(35.79%) | |||||
Distribution of the high-frequency major MeSH terms/MeSH subheadings of MRI studies on schizophrenia in PubMed from 2004 to 2018.
| Period | Threshold value of high- and low-frequency of MeSH terms | Number of high-frequency of MeSH terms | Frequency | Cumulative frequency | |
|---|---|---|---|---|---|
| Min | Max | ||||
| 2004-2008 | 26 | 26 | 26 | 327 | 49.0459% |
| 2009-2013 | 33 | 34 | 33 | 663 | 53.8805% |
| 2014-2018 | 36 | 36 | 36 | 605 | 52.1285% |
The high-frequency MeSH terms in each period can be seen in –.
Figure 2Bi-clustering analysis of 26 high-frequency MeSH terms/MeSH subheadings and literatures of MRI studies on schizophrenia in 2004 to 2008. (A) Matrix visualization of bi-clustering of 26 high-frequency major MeSH terms/MeSH subheadings and PubMed unique identifiers of literatures. (B) Mountain visualization of bi-clustering of 26 high-frequency major MeSH terms/MeSH subheadings and literatures.
Figure 4Bi-clustering analysis of 36 high-frequency major MeSH terms/MeSH subheadings and literatures of MRI studies on schizophrenia in 2014 to 2018. (A) Matrix visualization of bi-clustering of 36 high-frequency major MeSH terms/MeSH subheadings and PubMed unique identifier of literatures. (B) Mountain visualization of bi-clustering of 36 high-frequency major MeSH terms/MeSH subheadings and literatures.
Cluster interpretation of high-frequency major MeSH terms/MeSH subheadings of MRI studies on schizophrenia in PubMed from 2004 to 2018.
| Period | Cluster | Content and interpretation of the cluster | Rank of MeSH terms | Representative literatures (PMID) |
|---|---|---|---|---|
| 2004-2008 | Cluster 0 | Correlation between brain structural (e.g. cerebral cortex, prefrontal cortex) abnormalities and brain function changes to explore physiopathology mechanism of schizophrenia | 1, 3, 4, 5, 7, 8, 12, 17, 21, 23 | 17085018, 17913465, 16797186, 19042913 |
| Cluster 1 | 1. Neurodevelopmental abnormalities in patients with schizophrenia | 2, 6, 9, 10, 11, 14, 16, 24 | 18793730, 17166743, 17689500, 16179202 | |
| 2. Analysis of regional abnormal structural features and influencing factors of the brain | ||||
| Cluster 2 | 1. Analysis of metabolism, therapeutic efficacy of antipsychotic agents on brain structure | 13, 15, 18, 19, 20, 22, 25, 26 | 15201569, 17507880, 15520356, 16005383, 15809403 | |
| 2. Schizophrenia pathology (from the perspective of temporal lobe, prefrontal cortex and anatomy and histology of brain structure) | ||||
| 2009–2013 | Cluster 0 | Research on the physiopathology mechanism (from the perspective of frontal lobe, temporal lobe, prefrontal cortex, neural pathways) of schizophrenia and the etiology of cognitive disorder and other complications | 6, 10, 18, 22, 24, 26, 27, 28, 31 | 19097861, 20452574, 21868203, 19683896, 22105156 |
| Cluster 1 | 1. Research on brain structure and function (e.g. hippocampus, nerve fibers, cerebral cortex) and differentiate schizophrenia from bipolar disorder based on MRI | 1, 3, 8, 9, 11, 13, 16, 20, 23, 33, 34 | 24004694, 22832855, 20573561, 21878411, 19042913, 22945617 | |
| 2. MRI (including DTI) usages, image interpretations | ||||
| Cluster 2 | 1. Research on default mode network in schizophrenia patients | 2, 4, 5, 7, 12, 14, 15, 17, 19, 21, 25, 29, 30, 32 | 21095105, 21147518, 19931396, 21277171 | |
| 2. Schizophrenic psychology (association between anatomical and functional cerebral deficits with related clinical symptoms) | ||||
| 2014–2018 | Cluster 0 | Research on brain structural and functional abnormality (e.g. prefrontal cortex, nerve net) of patients with schizophrenia, as well as physiopathology mechanism of the disease | 1, 4, 12, 14, 15, 18, 19, 23, 27, 31, 32, 34 | 24306091, 26123450, 28338738, 29527474, 26908926, 28207073 |
| Cluster 1 | 1. Research on the difference of neurobiological basis between schizophrenia and other mental diseases | 2, 6, 10, 13, 16, 20, 21, 22, 24, 26, 29, 33, 35 | 28347393, 25904725, 25089761, 29257977, 25829144, 25968549 | |
| 2. Effects of antipsychotics on brain structural changes | ||||
| Cluster 2 | 1. Effects of genetic load on brain function of schizophrenia patients | 3, 5, 7, 8, 9, 11, 17, 25, 28, 30, 36 | 27479923, 27375133, 27829096, 29935206, 29247760 | |
| 2. Identification of schizophrenia biomarkers |
“Rank of MeSH terms” represents the number of high-frequency major MeSH terms/MeSH subheadings in each period as shown in –.
Descriptive statistics for centrality measures of MRI studies on schizophrenia from 2004 to 2018.
| Period | Density | Degree | Closeness | Betweenness | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Max | Min |
| Network centralization | Max | Min |
| Network centralization | Max | Min |
| Network centralization | ||
| 2004–2008 | 8.145±15.599 | 674.00 | 41.00 | 203.69 ± 184.44 | 17.88% | 100.00 | 62.50 | 79.90 ± 10.10 | 42.69% | 8.42 | 0.48 | 3.39 ± 2.38 | 1.74% |
| 2009–2013 | 8.080 ± 17.782 | 1311.00 | 73.00 | 266.65 ± 273.88 | 15.80% | 100.00 | 66.00 | 80.05 ± 9.82 | 41.76% | 10.61 | 0.61 | 4.41 ± 2.95 | 1.21% |
| 2014-2018 | 7.062 ± 16.209 | 1204.00 | 48.00 | 247.17 ± 241.62 | 13.47% | 97.22 | 64.82 | 81.18 ± 8.76 | 33.49% | 9.38 | 0.89 | 4.31 ± 2.33 | 0.88% |
Descriptive statistics for centrality measure about MRI studies on schizophrenia from 2004 to 2018.
| Period | Rank of MeSH terms | High-frequency MeSH terms/MeSH subheadings | Centrality | Rank of MeSH terms | High-frequency MeSH terms/MeSH subheadings | Centrality | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Degree | Betweenness | Closeness | Degree | Betweenness | Closeness | |||||
| 2004–2008 | 3 | Magnetic Resonance Imaging | 674.000 | 5.320 | 89.286 | 15 | Antipsychotic Agents/therapeutic use | 99.000 | 3.174 | 80.645 |
| 1 | Schizophrenia/physiopathology | 663.000 | 8.417 | 100.000 | 16 | Cerebral Cortex/pathology | 93.000 | 2.587 | 75.758 | |
| 4 | Schizophrenia/diagnosis | 461.000 | 8.417 | 100.000 | 14 | Brain Mapping | 91.000 | 1.650 | 71.429 | |
| 5 | Schizophrenic Psychology | 429.000 | 5.313 | 92.593 | 21 | Diffusion Magnetic Resonance Imaging | 86.000 | 1.927 | 71.429 | |
| 2 | Schizophrenia/pathology | 415.000 | 7.593 | 96.154 | 20 | Brain/anatomy & histology | 81.000 | 1.653 | 73.529 | |
| 7 | Image Processing, Computer-Assisted | 389.000 | 1.736 | 78.125 | 24 | Image Interpretation, Computer-Assisted/methods | 72.000 | 0.482 | 62.500 | |
| 6 | Brain/pathology | 299.000 | 3.682 | 80.645 | 25 | Temporal Lobe/pathology | 69.000 | 2.238 | 73.529 | |
| 8 | Brain/physiopathology | 275.000 | 5.543 | 86.207 | 11 | Schizophrenia/complications | 69.000 | 1.530 | 71.429 | |
| 9 | Schizophrenia/genetics | 178.000 | 7.441 | 96.154 | 23 | Cerebral Cortex/physiopathology | 67.000 | 1.454 | 71.429 | |
| 17 | Imaging, Three-Dimensional | 162.000 | 1.246 | 73.529 | 19 | Magnetic Resonance Imaging/statistics & numerical data | 65.000 | 1.313 | 71.429 | |
| 12 | Prefrontal Cortex/physiopathology | 144.000 | 3.388 | 80.645 | 26 | Prefrontal Cortex/pathology | 63.000 | 1.480 | 75.758 | |
| 10 | Magnetic Resonance Imaging/methods | 135.000 | 4.448 | 83.333 | 22 | Schizophrenia/epidemiology | 55.000 | 2.312 | 73.529 | |
| 13 | Schizophrenia/drug therapy | 121.000 | 2.806 | 80.645 | 18 | Schizophrenia/metabolism | 41.000 | 0.851 | 67.568 | |
| 2009– 2013 | 1 | Schizophrenia/pathology | 1322.000 | 10.606 | 100.000 | 16 | Psychotic Disorders/pathology | 140.000 | 4.133 | 80.488 |
| 2 | Schizophrenia/physiopathology | 909.000 | 9.658 | 97.059 | 27 | Neural Pathways/pathology | 127.000 | 4.210 | 80.488 | |
| 4 | Schizophrenic Psychology | 754.000 | 10.606 | 100.000 | 22 | Temporal Lobe/pathology | 114.000 | 3.411 | 78.571 | |
| 3 | Brain/pathology | 700.000 | 7.333 | 91.667 | 25 | Neural Pathways/physiopathology | 114.000 | 2.137 | 71.739 | |
| 5 | Brain/physiopathology | 488.000 | 5.934 | 84.615 | 23 | Bipolar Disorder/pathology | 114.000 | 1.953 | 71.739 | |
| 7 | Magnetic Resonance Imaging | 447.000 | 8.232 | 91.667 | 28 | Cognition Disorders/etiology | 113.000 | 2.103 | 71.739 | |
| 6 | Brain Mapping | 397.000 | 8.011 | 91.667 | 21 | Cerebral Cortex/physiopathology | 111.000 | 2.063 | 71.739 | |
| 10 | Schizophrenia/complications | 320.000 | 6.084 | 84.615 | 26 | Brain/blood supply | 111.000 | 0.794 | 67.347 | |
| 9 | Magnetic Resonance Imaging/methods | 302.000 | 6.204 | 84.615 | 20 | Hippocampus/pathology | 104.000 | 3.953 | 78.571 | |
| 8 | Schizophrenia/genetics | 281.000 | 9.526 | 97.059 | 29 | Emotions/physiology | 102.000 | 1.975 | 71.739 | |
| 12 | Schizophrenia/diagnosis | 246.000 | 7.139 | 89.189 | 34 | Image Interpretation, Computer-Assisted/methods | 100.000 | 1.012 | 67.347 | |
| 11 | Cerebral Cortex/pathology | 244.000 | 4.293 | 82.500 | 30 | Brain Mapping/methods | 98.000 | 2.873 | 75.000 | |
| 19 | Image Processing, Computer-Assisted | 204.000 | 3.886 | 78.571 | 24 | Prefrontal Cortex/pathology | 94.000 | 0.607 | 66.000 | |
| 13 | Nerve Fibers, Myelinated/pathology | 200.000 | 5.405 | 84.615 | 15 | Schizophrenia/drug therapy | 91.000 | 2.404 | 75.000 | |
| 17 | Nerve Net/physiopathology | 172.000 | 1.468 | 70.213 | 31 | Frontal Lobe/pathology | 86.000 | 3.229 | 76.744 | |
| 14 | Prefrontal Cortex/physiopathology | 155.000 | 2.383 | 71.739 | 33 | Diffusion Tensor Imaging/methods | 85.000 | 0.917 | 68.750 | |
| 18 | Memory, Short-Term/physiology | 148.000 | 4.309 | 78.571 | 32 | Antipsychotic Agents/therapeutic use | 73.000 | 1.154 | 70.213 | |
| 2014- 2018 | 1 | Schizophrenia/physiopathology | 1240.000 | 7.924 | 97.222 | 13 | Schizophrenia/complications | 166.000 | 7.320 | 89.744 |
| 2 | Schizophrenia/pathology | 945.000 | 8.434 | 97.222 | 21 | Cerebral Cortex/pathology | 155.000 | 4.272 | 79.545 | |
| 4 | Brain/physiopathology | 577.000 | 3.869 | 83.333 | 16 | Schizophrenia/drug therapy | 154.000 | 3.862 | 81.395 | |
| 3 | Schizophrenia/diagnostic imaging | 514.000 | 7.642 | 94.595 | 24 | Bipolar Disorder/pathology | 131.000 | 0.889 | 64.815 | |
| 5 | Schizophrenic Psychology | 466.000 | 7.722 | 94.595 | 23 | Brain Mapping/methods | 129.000 | 4.990 | 83.333 | |
| 6 | Brain/pathology | 407.000 | 5.881 | 85.366 | 17 | Schizophrenia/diagnosis | 126.000 | 5.120 | 83.333 | |
| 7 | Magnetic Resonance Imaging/methods | 360.000 | 9.382 | 97.222 | 34 | Bipolar Disorder/physiopathology | 117.000 | 1.391 | 70.000 | |
| 9 | Brain/diagnostic imaging | 279.000 | 2.225 | 76.087 | 27 | Memory, Short-Term/physiology | 113.000 | 1.535 | 71.429 | |
| 10 | White Matter/pathology | 262.000 | 5.741 | 87.500 | 25 | Brain Mapping | 111.000 | 4.194 | 79.545 | |
| 14 | Nerve Net/physiopathology | 240.000 | 4.592 | 83.333 | 30 | Psychotic Disorders/diagnostic imaging | 111.000 | 3.946 | 81.395 | |
| 15 | Psychotic Disorders/physiopathology | 237.000 | 5.823 | 89.744 | 28 | White Matter/diagnostic imaging | 108.000 | 2.059 | 72.917 | |
| 8 | Schizophrenia/genetics | 213.000 | 7.621 | 92.105 | 29 | Diffusion Tensor Imaging/methods | 107.000 | 4.112 | 74.468 | |
| 11 | Magnetic Resonance Imaging | 205.000 | 7.086 | 89.744 | 26 | Antipsychotic Agents/therapeutic use | 101.000 | 2.463 | 72.917 | |
| 12 | Prefrontal Cortex/physiopathology | 198.000 | 2.618 | 76.087 | 32 | Neural Pathways/physiopathology | 99.000 | 1.663 | 72.917 | |
| 19 | Connectome/methods | 194.000 | 3.040 | 79.545 | 31 | Emotions/physiology | 93.000 | 2.463 | 76.087 | |
| 18 | Cerebral Cortex/physiopathology | 182.000 | 2.482 | 77.778 | 35 | Prefrontal Cortex/pathology | 88.000 | 3.268 | 76.087 | |
| 22 | Psychotic Disorders/pathology | 176.000 | 2.386 | 72.917 | 33 | Hippocampus/pathology | 78.000 | 1.446 | 70.000 | |
| 20 | Gray Matter/pathology | 168.000 | 4.280 | 79.545 | 36 | Schizophrenia/metabolism | 48.000 | 1.257 | 68.627 | |
“Rank of MeSH terms” represents the number of high-frequency major MeSH terms/MeSH subheadings in each period as shown in –.
Figure 6SNA for high-frequency major MeSH terms/MeSH subheadings applied to MRI studies on schizophrenia. (A) SNA for 26 high-frequency major MeSH terms/MeSH subheadings in 2004–2008. (B) SNA for 34 high-frequency major MeSH terms/MeSH subheadings in 2009–2013. (C) SNA for 36 high-frequency major MeSH terms/MeSH subheadings in 2014–2018. The size of the nodes and the thickness of the lines within the networks represent centrality of MeSH terms and the co-occurrence frequency of MeSH terms pairs, respectively. Red icons ( Node with the highest betweenness centrality. Circle icons: Nodes highly co-occurred with other nodes since the period of 2004–2008 (), 2009–2013 () and 2014–2018 (), respectively (). Box icons: Emerging nodes in 2004–2008 (), 2009–2013 () and 2014–2018(), respectively.